Pentoxifylline and Tocopherol (PENTO) in the Treatment of Medication-related Osteonecrosis of the Jaw (MRONJ)
Pentoxifylline and Tocopherol (PENTO) in the Treatment of Medication-related Osteonecrosis of the Jaw (MRONJ)
Active, not recruiting · NCT03040778 · Registry updated 2026-04-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Pentoxifylline and Tocopherol (PENTO) in the Treatment of Medication-related Osteonecrosis of the Jaw (MRONJ) | Bisphosphonate-Associated Osteonecrosis of the Jaw, Jaw Diseases, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Stomatognathic Diseases, avascular necrosis, bone disorder, musculoskeletal system disorder, osteonecrosis | Active, not recruiting | Phase 3 | 2026-04-29 | NCT03040778 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| New York Center for Orthognathic and Maxillofacial Surgery | 1 |
| University of Alabama at Birmingham | 467 |
| University of Michigan | 394 |
| University of Washington | 397 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| New York Center for Orthognathic and Maxillofacial Surgery | Lake Success | United States | 1 |
| University of Alabama at Birmingham | Birmingham | United States | 1 |
| University of Michigan | Ann Arbor | United States | 1 |
| University of Washington | Seattle | United States | 172 |